1. Home
  2. LDOS vs NTRA Comparison

LDOS vs NTRA Comparison

Compare LDOS & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Leidos Holdings Inc.

LDOS

Leidos Holdings Inc.

HOLD

Current Price

$187.48

Market Cap

23.9B

Sector

Technology

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$244.06

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LDOS
NTRA
Founded
1969
2003
Country
United States
United States
Employees
48000
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.9B
27.0B
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
LDOS
NTRA
Price
$187.48
$244.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
16
Target Price
$204.91
$227.69
AVG Volume (30 Days)
751.8K
1.7M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
0.92%
N/A
EPS Growth
22.34
N/A
EPS
10.68
N/A
Revenue
$17,332,000,000.00
$2,116,676,000.00
Revenue This Year
$5.17
$32.77
Revenue Next Year
$3.59
$16.51
P/E Ratio
$17.49
N/A
Revenue Growth
6.48
38.17
52 Week Low
$123.62
$125.38
52 Week High
$205.77
$245.59

Technical Indicators

Market Signals
Indicator
LDOS
NTRA
Relative Strength Index (RSI) 44.52 80.03
Support Level $186.27 $233.67
Resistance Level $196.56 $240.18
Average True Range (ATR) 4.19 7.39
MACD -0.23 0.68
Stochastic Oscillator 21.72 97.49

Price Performance

Historical Comparison
LDOS
NTRA

About LDOS Leidos Holdings Inc.

Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health markets, both domestically and internationally. Company customer includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in four reportable segments; National Security & Digital, Health & Civil, Commercial & International and Defense Systems. It provides a wide array of scientific, engineering and technical services and solutions across these reportable segments.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: